Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Signal transducer and activator of transcription 3 (STAT3) and telomerase are considered attractive targets for anticancer therapy. The in vitro anticancer activity of the gold(I) compound auranofin was investigated using MDA-MB 231 human breast cancer cells, in which STAT3 is constitutively active. In cell culture, auranofin inhibited growth in a dose-dependent manner,and N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS), markedly blocked the effect of auranofin. Incorporation of 5-bromo-2’-deoxyuridine into DNA and anchorage-independent cell growth on soft agar were decreased by auranofin treatment. STAT3 phosphorylation and telomerase activity were also attenuated in cells exposed to auranofin, but NAC pretreatment restored STAT3 phosphorylation and telomerase activity in these cells. These findings indicate that auranofin exerts in vitro antitumor effects in MDA-MB 231 cells and its activity involves inhibition of STAT3 and telomerase. Thus, auranofin shows potential as a novel anticancer drug that targets STAT3 and telomerase.
Abstract
Signal transducer and activator of transcription 3 (STAT3) and telomerase are considered attractive targets for anticancer therapy. The in vitro anticancer activity of the gold(I) compound auranofin was investigated using MDA-MB 231 human breast cancer cells, in which STAT3 is constitutively active. In cell culture, auranofin inhibited growth in a dose-dependent manner,and N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS), markedly blocked the effect of auranofin. Incorporation of 5-bromo-2’-deoxyuridine into DNA and anchorage-independent cell growth on soft agar were decreased by auranofin treatment. STAT3 phosphorylation and telomerase activity were also attenuated in cells exposed to auranofin, but NAC pretreatment restored STAT3 phosphorylation and telomerase activity in these cells. These findings indicate that auranofin exerts in vitro antitumor effects in MDA-MB 231 cells and its activity involves inhibition of STAT3 and telomerase. Thus, auranofin shows potential as a novel anticancer drug that targets STAT3 and telomerase.
참고문헌 (28)
- Komeda, S., "Next-generation anticancer metallodrugs", Curr. Top. Med. Chem, 12, pp.219~235 (2012)
- Ott, I., "Non platinum metal complexes as anti-cancer drugs", Arch. Pharm. Chem. Life Sci, 340, pp.117~126 (2007)
- Borg, G., "Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study", J. Rheumatol, 15, pp.1747~1754 (1988)
- Kean, W. F., "Clinical pharmacology of gold", Inflammopharmacology, 16, pp.112~125 (2008)
- Kye-ImJeon, "Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit", Experimental and Molecular Medicine, 35(2), pp.61~66 (2003), 생화학분자생물학회
- Angelucci, F., "Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects", J. Biol. Chem, 284, pp.28977~28985 (2009)
- Gromer, S., "Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds", J. Biol. Chem, 273, pp.20096~20101 (1998)
- Mustacich, D., "Thioredoxin reductase", Biochem. J, 346(Pt 1), pp.1~8 (2000)
- Biaglow, J. E, "The thioredoxin reductase", thioredoxin system: novel redox targets for cancer therapy, 2005, pp.4, 6~13
- Powis, G., "Thioredoxin signaling as a target for cancer therapy", Curr. Opin. Pharmacol, 7, pp.392~397 (2007)
- Urig, S, "On the potential of thioredoxin reductase inhibitors for cancer therapy", Semin. Cancer Biol, 16, pp.452~465 (2006)
- Rigobello, M. P., "Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c", Biochem. Pharmacol, 67, pp.689~696 (2004)
- Gandin, V., "Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase", Biochem. Pharmacol, 79, pp.90~101 (2010)
- Kim, I. S., "Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro", J. Pharmacol, 142, pp.749~755 (2004)
- Park, S. J., "The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells", Br. J. Pharmacol, 146, pp.506~513 (2005)
- Marzano, C., "Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells", Free Radic. Biol. Med, 42, pp.872~881 (2007)
- Tiekink, E. R., "Anti-cancer potential of gold complexes", Inflammopharmacology, 16, pp.138~142 (2008)
- Nobili, S., "Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies", Med. Res. Rev, 30, pp.550~580 (2010)
- Hirano, T., "Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors", Oncogene, 19, pp.2548~2556 (2000)
- Chen, Z., "STAT3: a critical transcription activator in angiogenesis", Med. Res. Rev, 28, pp.185~200 (2008)
- Garcia, R., "Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells", Oncogene, 20, pp.2499~2513 (2001)
- Su, F., "Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer", Breast Cancer Res, 14, pp.R38~ (2012)
- Konnikova, L., "Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells", Cancer Res, 65, pp.6516~6520 (2005)
- Lavecchia, A., "STAT-3 inhibitors: state of the art and new horizons for cancer treatment", Curr. Med. Chem, 18, pp.2359~2375 (2011)
- Kim, N. H., "Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3", Immunology, 122, pp.607~614 (2007)
- Nakaya, A., "The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-kappaB activity", Leuk. Res, 35, pp.243~249 (2011)
- Dixit, D., "Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation", Free Radic. Biol. Med, 47, pp.364~374 (2009)
- Watson, W. H., "Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation", Biochem. Biophys. Res. Commun, 368, pp.832~836 (2008)